Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Global Hemp Group Inc. (C:GHG)

Business Focus: Medical Farming

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
Company Contact
Address: #106 - 1169 Mt. Seymour Road
NORTH VANCOUVER BC V7H 2Y4
Tel: N/A
Website: https://globalhempgroup.com
IR: See website
Key People
N/A    
Business Overview
Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Company's has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.
Financial Overview
For the nine months ended 30 June 2023, Global Hemp Group Inc revenues was not reported. Net loss increased from C$54K to C$282K. Higher net loss reflects FV/Uls Adjust on Derivatives for Hedging decrease of 53% to C$230K (income), Interest and bank charges increase of 39% to C$391K (expense), Government Loan Forgiveness decrease from C$79K (income) to C$0K. Basic Earnings per Share excluding Extraordinary Items totaled to -C$0.02.
Reporting Currency: Canadian Dollars
Enterprise value: $4.23M as of Jun 30, 2023
Annual revenue (TTM): $0.00M as of Jun 30, 2023
EBITDA (TTM): -$1.38M as of Jun 30, 2023
Net annual income (TTM): -$2.39M as of Jun 30, 2023
Free cash flow (TTM): -$0.10M as of Jun 30, 2023
Net Debt Last Fiscal Year: $3.48M as of Jun 30, 2023
Shares outstanding: 24,291,458 as of Feb 1, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization